中国医学科学院学报

高级检索
中国医学科学院学报

中国医学科学院学报 ›› 2021, Vol. 43 ›› Issue (4): 595-602.doi: 10.3881/j.issn.1000-503X.13645

• 论著 • 上一篇    下一篇

Wnt通路中亮氨酸重复序列G蛋白偶联受体5/6在儿童急性淋巴细胞白血病中的表达及意义

李宣,王文鹏,周敏,徐晓蕊,高吉照()   

  1. 徐州医科大学附属医院儿科,江苏徐州 221002
  • 收稿日期:2020-12-14 出版日期:2021-08-30 发布日期:2021-09-03
  • 通讯作者: 高吉照 E-mail:xz3765595@163.com

Expression and Significance of Leucine-rich Repeat-containing G-protein Coupled Receptor 5/6 in Wnt Pathway in Children with Acute Lymphoblastic Leukemia

LI Xuan,WANG Wenpeng,ZHOU Min,XU Xiaorui,GAO Jizhao()   

  1. Department of Pediatrics,The Affiliated Hospital of Xuzhou Medical University,Xuzhou,Jiangsu 221002,China
  • Received:2020-12-14 Published:2021-08-30 Online:2021-09-03
  • Contact: GAO Jizhao E-mail:xz3765595@163.com

摘要:

目的 研究富含亮氨酸重复序列G蛋白偶联受体(LGR)5/6在儿童急性淋巴细胞白血病(ALL)中的表达及意义。方法 选取39例经诱导化疗后第33天骨髓达完全缓解的ALL患儿,诱导化疗前作为初发组,经诱导化疗第33天骨髓达完全缓解时作为缓解组,根据危险度分层再分为低危(n=16)、中危(n=9)和高危组(n=14)。30例免疫性血小板减少症的患儿为对照组。留取初发组、缓解组及对照组骨髓血3 ml,采用实时荧光定量聚合酶链反应法检测骨髓细胞中LGR5和LGR6 mRNA的相对表达,采用Western blot法检测骨髓细胞中LGR5和LGR6蛋白的相对表达。结果 初发组LGR5 mRNA(0.850±0.279)及蛋白(0.083±0.027)的相对表达均低于缓解组(mRNA:1.418±0.324,蛋白:0.130±0.033)与对照组(mRNA:1.541±0.409,蛋白:0.138±0.041)(PmRNA=0.000,P蛋白=0.000),初发组LGR6 mRNA(2.444±1.160)及蛋白(0.298±0.088)的相对表达均高于缓解组(mRNA:0.886±0.390,蛋白:0.111±0.039)与对照组(mRNA:0.928±0.373,蛋白:0.094±0.037)(PmRNA=0.000,P蛋白=0.000)。在初发组中,低危患儿LGR5 mRNA(1.004±0.284)及蛋白(0.097±0.030)的相对表达均高于中危(mRNA:0.728±0.239,蛋白:0.071±0.022)和高危患儿(mRNA:0.752±0.222,蛋白:0.074±0.020)(PmRNA=0.012,P蛋白=0.016),低危患儿LGR6 mRNA(1.822±0.979)及蛋白(0.245±0.077)的相对表达均低于中危(mRNA:2.954±1.039,蛋白:0.338±0.081)和高危患儿(mRNA:2.827±1.165,蛋白:0.333±0.075)(PmRNA=0.016,P蛋白=0.004)。在缓解组中,低危患儿LGR5 mRNA(1.597±0.329)及蛋白(0.150±0.035)的相对表达均高于中危(mRNA:1.277±0.288,蛋白:0.117±0.029)和高危患儿(mRNA:1.305±0.253,蛋白:0.116±0.023)(PmRNA=0.012,P蛋白=0.006),低危患儿LGR6 mRNA(0.662±0.334)及蛋白(0.089±0.034)的相对表达均低于中危(mRNA:1.066±0.273,蛋白:0.130±0.033)和高危患儿(mRNA:1.027±0.405,蛋白:0.126±0.038)(PmRNA=0.007,P蛋白=0.007)。结论 LGR5和LGR6的表达与儿童ALL的发生和危险度有关,其具体作用机制有待进一步研究。

关键词: 急性淋巴细胞白血病, Wnt通路, 亮氨酸重复序列G蛋白偶联受体

Abstract:

Objective To study the expression and significance of leucine-rich repeat-containing G-protein coupled receptor(LGR)5/6 in childhood acute lymphoblastic leukemia(ALL). Methods A total of 39 children who had ALL and achieved complete remission on day 33 after induction therapy were enrolled.The children before induction therapy were considered as the incipient group,and those who achieved complete remission on day 33 by induction therapy were considered as the remission group.According to the degree of risk,they were assigned into 3 groups:low-risk(n=16),intermediate-risk(n=9),and high-risk(n=14)groups.A total of 30 children with immune thrombocytopenia were taken as the control group.From each child in the incipient group,remission group,and control group,3 ml bone marrow sample was collected.Real-time fluorescent quantitative polymerase chain reaction was conducted to measure the mRNA expression of LGR5 and LGR6 in the blood cells of bone marrow.Western blot was employed to measure the protein expression of LGR5 and LGR6 in blood cells of bone marrow. Results Compared with the control(mRNA:1.541±0.409,protein:0.138±0.041)and remission(mRNA:1.418±0.324,protein:0.130±0.033)groups,the incipient group had significantly lower mRNA(0.850±0.279)and protein(0.083±0.027)expression of LGR5(PmRNA=0.000,Pprotein=0.000).Compared with the control(mRNA:0.928±0.373,protein:0.094±0.037)and remission(mRNA:0.886±0.390,protein:0.111±0.039)groups,the incipient group had significantly higher mRNA(2.444±1.160)and protein(0.298±0.088)expression of LGR6(PmRNA=0.000,Pprotein=0.000).In the incipient groups,low-risk children showed significantly higher mRNA(1.004±0.284)and protein(0.097±0.030)expression of LGR5 than the intermediate-risk children(mRNA:0.728±0.239,protein:0.071±0.022)and high-risk children(mRNA:0.752±0.222,protein:0.074±0.020)(PmRNA=0.012,Pprotein=0.016);low-risk children showed significantly lower mRNA(1.822±0.979)and protein(0.245±0.077)expression of LGR6 than the intermediate-risk children(mRNA:2.954±1.039,protein:0.338±0.081)and high-risk children(mRNA:2.827±1.165,protein:0.333±0.075)(PmRNA=0.016,Pprotein=0.004).In the remission groups,low-risk children showed significantly higher mRNA(1.597±0.329)and protein(0.150±0.035)expression of LGR5 than the intermediate-risk children(mRNA:1.277±0.288,protein:0.117±0.029)and high-risk children(mRNA:1.305±0.253,protein:0.116±0.023)(PmRNA=0.012,Pprotein=0.006);low-risk children showed significantly lower mRNA(0.662±0.334)and protein(0.089±0.034)expression of LGR6 than the intermediate-risk children(mRNA:1.066±0.273,protein:0.130±0.033)and high-risk children(mRNA:1.027±0.405,protein:0.126±0.038)(PmRNA=0.007,Pprotein=0.007). Conclusion The expression of LGR5 and LGR6 are closely related to the occurrence and risk of childhood ALL,but its mechanism needs further study.

Key words: acute lymphoblastic leukemia, Wnt pathway, leucine-rich repeat-containing G-protein coupled receptor

中图分类号: